Randall Michael Giuffre serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Randall Michael Giuffre has executed 17 insider transactions totaling $560.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 2, 2024 involved receiving (via award) 19,196 shares valued at $53.7K.
Randall Michael Giuffre currently holds 364,551 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randall Michael Giuffre has been a net buyer of DMAC stock. They have purchased $560.2K and sold $0 worth of shares.
Randall Michael Giuffre's most recent insider trade was on Jan 2, 2024, when they sold 19,196 shares at $2.80 per share.
Get notified when new Form 4 filings are submitted
| $3.91 |
| Discretionary |
| Jun 23, 2023 | DMAC | $0 | Gift | 15,000 | $N/A | Discretionary |
| Jan 3, 2023 | DMAC | $53.7K | Award | 35,130 | $1.53 | Discretionary |
| Dec 9, 2022 | DMAC | $53.0K | Purchase | 37,079 | $1.43 | Discretionary |
| Dec 8, 2022 | DMAC | $28.0K | Purchase | 20,000 | $1.40 | Discretionary |
| Dec 7, 2022 | DMAC | $31.6K | Purchase | 22,574 | $1.40 | Discretionary |
| Dec 6, 2022 | DMAC | $3.1K | Purchase | 2,300 | $1.35 | Discretionary |
| Dec 1, 2022 | DMAC | $55.4K | Purchase | 46,133 | $1.20 | Discretionary |
| Dec 1, 2022 | DMAC | $975 | Purchase | 819 | $1.19 | Discretionary |
| Nov 30, 2022 | DMAC | $3.5K | Purchase | 2,970 | $1.19 | Discretionary |
| Nov 29, 2022 | DMAC | $21.6K | Purchase | 18,125 | $1.19 | Discretionary |
| Jan 3, 2022 | DMAC | $53.8K | Award | 15,026 | $3.58 | Discretionary |
| Jan 1, 2021 | DMAC | $61.2K | Award | 7,441 | $8.23 | Discretionary |
| Nov 20, 2020 | DMAC | $63.9K | Purchase | 15,000 | $4.26 | Discretionary |
| Jun 1, 2020 | DMAC | $35.7K | Award | 7,784 | $4.59 | Discretionary |
| Dec 11, 2018 | DMAC | $45.0K | Purchase | 11,250 | $4.00 | Discretionary |